SINOPHARMA
ActiveSummary
SINOPHARMA has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12,765 and a net result of €3,218. Equity is growing by about 4.8% per year across the filed financial years. Its solvency ranks better than 37% of 22,576 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
History
Acts, filings and financial milestones
28-12
Gazette deed
Resignation: Richard ZAGORSKI (manager)Appointment: Richard ZAGORSKI (administrateurnonstatutaire) · Director discharge · Registered office clause14 facts ▸
- Director resignation, Richard ZAGORSKI (manager)
- Director discharge, Richard ZAGORSKI (manager)
- Director appointment, Richard ZAGORSKI (administrateurnonstatutaire)
- Other provision, “2023-05-04créantRegistrecentraldesinterdictionsdegérer, Absenced'interdictiondegérer” (deed in French)
- Registered office clause, “7700Mouscron,Ruedel'Atre59, Sixièmerésolution,adressesiègen'étantplusstatutaire,confirmationadresseactuelle” (deed in French)
- General meeting, 04-12-2023
- Legal-form conversion, “société à responsabilité limitée” (deed in French)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Other provision, “conversion et suppression du compte de capitaux propres indisponible, sommes entièrement disponibles pour distribution future éventuelle” (deed in French)
- Amendment of the articles (2 times)
- Other provision, “introduction appels de fonds et reformulation apports en numéraire” (deed in French)
- Other provision, “adaptation administration et représentation externe” (deed in French)
- +2 further facts in this act
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.